MTR Corporation Limited (MTCPY)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,331	21,718	24,115	32,890	33,240	34,559
Market Cap Growth	-9.94%	-9.94%	-26.68%	-1.05%	-3.82%	-5.08%
Enterprise Value	29,477	27,702	28,591	36,515	36,938	38,827
Last Close Price	11.16	10.37	10.87	14.05	14.29	14.49
PE Ratio	11.00	10.70	24.20	26.10	27.14	-
PS Ratio	2.89	2.81	3.31	5.36	5.49	6.30
PB Ratio	0.93	0.91	1.05	1.43	1.44	1.51
P/TBV Ratio	1.19	1.16	1.33	1.79	1.79	1.86
P/OCF Ratio	9.38	9.12	16.82	37.95	34.69	347.08
EV/Sales Ratio	3.86	3.59	3.92	5.96	6.10	7.08
EV/EBITDA Ratio	8.15	8.06	14.96	14.91	14.83	27.18
EV/EBIT Ratio	10.39	10.29	24.33	21.24	21.25	49.60
EV/FCF Ratio	-150.83	-	-	-	-	-
Debt / Equity Ratio	0.42	0.42	0.34	0.27	0.24	0.29
Debt / EBITDA Ratio	2.88	2.88	3.92	2.48	2.22	4.42
Asset Turnover	0.17	0.17	0.17	0.15	0.16	0.15
Inventory Turnover	8.63	8.63	9.28	11.12	11.48	10.45
Quick Ratio	1.35	1.35	1.32	1.20	1.39	1.38
Current Ratio	1.71	1.71	1.81	1.55	2.05	2.02
Return on Equity (ROE)	8.80%	8.80%	4.51%	5.63%	5.42%	-2.65%
Return on Assets (ROA)	3.66%	3.66%	1.70%	2.71%	2.91%	1.31%
Return on Capital (ROIC)	5.20%	5.20%	2.46%	3.71%	3.75%	1.67%
Return on Capital Employed (ROCE)	6.20%	6.20%	2.90%	4.40%	5.00%	2.20%
Earnings Yield	9.09%	9.35%	4.13%	3.83%	3.69%	-1.80%
FCF Yield	-0.88%	-0.90%	-0.60%	-4.88%	-0.45%	-2.00%
Dividend Yield	3.59%	1.63%	1.54%	1.20%	1.14%	1.09%
Payout Ratio	50.38%	50.38%	97.57%	87.13%	75.01%	-
Buyback Yield / Dilution	-0.21%	-0.21%	-0.19%	-0.16%	-0.40%	-0.19%
Total Shareholder Return	3.38%	1.42%	1.36%	1.04%	0.74%	0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.